Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
Camilla Krakstad(Haukeland University Hospital), Helga B. Salvesen(Haukeland University Hospital)
Cited by 61
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome
|Clinical Cancer Research|2012|162
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
|British Journal of Cancer|2012|84
Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
|Communications Medicine|2021|51